Baber Research Group /ID# 232279 — Naperville, Illinois

Baber Research Group /ID# 232279 is a clinical research site located in Naperville, Illinois, United States 60563-6502.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Baber Research Group /ID# 232279 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Depression, Bipolar I Disorder.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Baber Research Group /ID# 232279?

Baber Research Group /ID# 232279 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Baber Research Group /ID# 232279 conducted?

Baber Research Group /ID# 232279 has 1 clinical trials on record, with 1 currently active. Their work covers Depression, Bipolar I Disorder.

Is Baber Research Group /ID# 232279 accredited by Crixeo Health?

Baber Research Group /ID# 232279 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Baber Research Group /ID# 232279?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.